New Team member

News

MALASSA Project Launched: NovoArc Develops Lipid Nanoparticle Platform for a New Antibody Therapy Against Lassa Fever

At the kick-off meeting in Amsterdam, the partners of the MALASSA project met in person for the first time. NovoArc is part of the consortium and contributes its expertise in lipid nanoparticles.

Read more

Eurostars project NO-PNP launched: a new approach to neuropathic pain

Together with Akasi Pharma and IVRS AB, NovoArc is developing a long-acting, non-opioid treatment for neuropathic pain. NovoArc is contributing its liposomal TEL platform to the project.

Read more

Gold for NovoArc at the Born Global Champion Awards

The award honors companies that successfully enter international markets at an early stage, demonstrate strong export performance, and show the potential to create lasting global impact.

Read more

Recognized Among Austria’s Top 100 Startups

We’re incredibly proud to share that our company has been selected for TREND Magazine’s 2025 ranking of Austria’s Top 100 Startups.

Read more

More Than Teammates

Sometimes the most important work happens away from our desks.

Read more

A Visit from District Mayor Zankl

We were delighted to welcome District Mayor Zankl to our facility.

Read more